person

Wolfgang W.

Country
Austria
Department
#3050:Haematology Oncology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
75
Sites with multiple studies

Has run more than one trial at 75 of 244 partner sites.

Specializations

Multiple Myeloma Research

The investigator specializes in treating newly diagnosed multiple myeloma, with particular focus on innovative therapeutic combinations and maintenance strategies following autologous stem cell transplantation.

  • Post-transplant maintenance therapy
  • Novel drug combinations
  • Treatment response monitoring

Expertise extends to evaluating minimal residual disease (MRD) monitoring techniques and treatment outcomes in transplant-eligible and ineligible patients.

Advanced Therapeutics

Focuses on investigating targeted therapies including novel antibody treatments and combination approaches for hematologic malignancies.

  • Monoclonal antibody therapy
  • Immunomodulatory treatments
  • Combination therapy strategies

Investigates the effectiveness of multi-drug regimens in improving patient outcomes and treatment responses.

Lymphoma Studies

Conducts research in diffuse large B-cell lymphoma (DLBCL), particularly focusing on high-risk and high-intermediate risk patients.

  • Novel therapeutic combinations
  • Standard therapy optimization
  • Risk-stratified treatment approaches

Specializes in evaluating enhanced treatment protocols incorporating immunotherapy with standard care regimens.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.